Results of using the neuroprotective drug Cellex in non-traumatic intracranial hemorrhage
Introduction. In the Russian Federation, neuroprotective agents are widely used in the treatment of patients with ischemic stroke. There are accumulated data on the efficacy and safety of the neuroprotective agent Cellex® in ischemic stroke. The use of this drug in hemorrhagic stroke has been studie...
Auteurs principaux: | Kh. D. Mongush, A. V. Kyrgys, A. A. Sedip, A. E. Shyyrap, A. B. Ondar, M. G. Zhestikova |
---|---|
Format: | Article |
Langue: | Russian |
Publié: |
Remedium Group LLC
2022-03-01
|
Collection: | Медицинский совет |
Sujets: | |
Accès en ligne: | https://www.med-sovet.pro/jour/article/view/6755 |
Documents similaires
-
Efficacy of Cellex in patients with mild cognitive impairment
par: B. A. Abusueva, et autres
Publié: (2019-04-01) -
NEUROPROTECTION INFLUENCE ON COURSE OF CEREBRAL STROKE
par: G. N. BELSKAYA, et autres
Publié: (2016-12-01) -
Neuroprotection by Ozanimod Following Intracerebral Hemorrhage in Mice
par: Fei Wang, et autres
Publié: (2022-06-01) -
Drug-induced non-traumatic intracranial hemorrhage associated with the use of anticoagulants and antiplatelet agents
par: O. D. Ostroumova, et autres
Publié: (2022-12-01) -
Acute albumin administration as therapy for intracerebral hemorrhage: A literature review
par: Yirong Cao, et autres
Publié: (2024-01-01)